Pacific 8 Ventures

About The Fund

Pacific 8 Ventures is a venture capital firm based in Taiwan with a specialized focus on the intersection of disruptive technology platforms and healthcare. They actively invest in innovative companies that are at the seed stage and have the potential to transform the healthcare landscape, often preferring to be the first institutional investor. Pacific 8 Ventures demonstrates a commitment to nurturing and guiding early-stage ventures and has a diversified investment portfolio that covers a range of sectors such as healthcare technology, information technology, robotics, artificial learning and machine learning, 3D printing, insurance technology, and blockchain. Their investment thesis emphasizes the importance of transformative therapeutics, diagnostics, and broader health services technologies. Although they maintain a global outlook, their geographic focus lies primarily in the US market, which they identify as the largest and most ripe for disruptive innovations in their sectors of interest. Some of the recent investments made by Pacific 8 Ventures include Matrisome Bio, Health Harbor, Certainly Health, Empirical Health, Laguna Bio, Mammoth Biosciences, Bunkerhill, BillionToOne, Interface Biosciences, Fauna Bio, and Dorian Therapeutics. Through their website, they offer insights into their team, a showcase of their portfolio companies, and updates on relevant news. Pacific 8 Ventures aims to build technology companies that have a significant and positive impact on healthcare systems globally.